生まれながらの免疫アダプタータンパク質MAVS,STING,TRIFのリン酸化により,IRF3の活性化が誘発される
まとめ
この研究では,アダプタータンパク質MAVSとSTINGのリン酸化が,インターフェロン調節因子3 (IRF3) の募集と活性化において,タイプIインターフェロン (IFN) の抗ウイルス反応の開始において極めて重要であることが明らかになりました.
科学分野:
- 免疫学 免疫学とは
- 分子生物学は分子生物学である.
- ウイルス学 ウイルス学 ウイルス学
背景:
- MAVSとSTINGは,細胞塩基核酸センサーRIG-IとcGASから信号を発する重要なアダプタタンパク質です.
- このシグナル伝達経路は,ウイルス感染症中にI型インターフェロン (IFN) および他の抗ウイルス分子を誘導するために不可欠です.
研究 の 目的:
- MAVSとSTINGがインターフェロン調節因子3 (IRF3) を活性化するメカニズムを調査する.
- IRF3.3の募集と活性化におけるリン酸化の役割を解明する.
主な方法:
- キナーゼアッセイを用いてMAVSとSTINGのリン酸化部位を調査した.
- コイムノプレシピテーションによる,リン酸化アダプターとIRF3の相互作用を分析した.
- 刺激に対する反応としてTBK1キナーゼによるIRF3活性化を研究した.
主要な成果:
- MAVSとSTINGは,IKKおよび/またはTBK1.1によってリン酸化されたセリンとセロニンクラスターを保存しています.
- 酸化されたMAVSとSTINGは,IRF3上の正電荷の表面に結合し,TBK1媒介の酸化と活性化のためにそれを募集します.
- トール型受容体アダプターであるTRIFは,同様のリン酸化依存メカニズムでIRF3を活性化します.
結論:
- 生まれながらの免疫アダプタータンパク質のリン酸化は,選択的なIRF3の徴募のための保存されたメカニズムです.
- このリン酸化に依存する募集は,ウイルス感染症に対するI型インターフェロン経路の活性化に不可欠です.
関連する概念動画
The JAK-STAT Signaling Pathway
14.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
14.2K
MAPK Signaling Cascades
9.5K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.5K
IP3/DAG Signaling Pathway
16.2K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
16.2K
Phosphoinositides and PIPs
11.8K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
11.8K
NF-κB-dependent Signaling Pathway
10.9K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
10.9K
PI3K/mTOR/AKT Signaling Pathway
6.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
6.5K


